I 
115TH CONGRESS 
2D SESSION 
H. R. 7079 
To authorize the Attorney General to make grants to, and enter into coopera-
tive agreements with, States and units of local government to develop, 
implement, or expand a program to provide medication-assisted treat-
ment, from arrest to release, to individuals incarcerated in the jurisdic-
tion who are addicted to opioids, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 19, 2018 
Ms. KUSTER of New Hampshire (for herself, Mrs. WALORSKI, Ms. JAYAPAL, 
Ms. BASS, Mr. CICILLINE, Ms. ESTY of Connecticut, Mr. TURNER, and 
Mr. LANGEVIN) introduced the following bill; which was referred to the 
Committee on the Judiciary 
A BILL 
To authorize the Attorney General to make grants to, and 
enter into cooperative agreements with, States and units 
of local government to develop, implement, or expand 
a program to provide medication-assisted treatment, from 
arrest to release, to individuals incarcerated in the juris-
diction who are addicted to opioids, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
21:17 Oct 19, 2018
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7079.IH
H7079
pamtmann on DSKBFK8HB2PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Corrections Public 
Health and Community Re-entry Act of 2018’’. 
SEC. 2. MEDICATION ASSISTED TREATMENT COMMUNITY 
RE-ENTRY PROGRAM. 
(a) AUTHORIZATION.—The Attorney General, acting 
through the Director of the National Institute of Correc-
tions, is authorized to make grants to, and enter into coop-
erative agreements with, States and units of local govern-
ment to develop, implement, or expand a program to pro-
vide medication-assisted treatment to individuals incarcer-
ated in the jurisdiction who are addicted to opioids. 
(b) PURPOSES.—The purposes of the program under 
this section are to— 
(1) develop medication-assisted treatment pro-
grams, in consultation with nonprofit organizations 
qualified to provide technical support for such pro-
grams; 
(2) reduce the risk of overdose to individuals 
following release from incarceration; and 
(3) reduce the rate of recidivism. 
(c) PROGRAM
REQUIREMENTS.—A program de-
scribed in subsection (a) which is funded by a grant or 
a cooperative agreement under this section shall include 
the following: 
VerDate Sep 11 2014 
21:17 Oct 19, 2018
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7079.IH
H7079
pamtmann on DSKBFK8HB2PROD with BILLS
(1) A sufficient number of providers who can 
prescribe (or otherwise dispense) and discuss with 
patients the risks of, benefits of, and differences be-
tween— 
(A) not less than 1 opioid antagonist medi-
cation approved by the Food and Drug Admin-
istration to treat addiction involving opioids; 
and 
(B) not less than 1 opioid agonist (or par-
tial agonist) medication approved by the Food 
and Drug Administration to treat addiction in-
volving opioids. 
(2) A certified recovery coach to work with 
newly released individuals recovering from addiction 
to opioids, in order to support the individual’s sus-
tained recovery. 
(d) APPLICATION.—A jurisdiction seeking a grant or 
cooperative agreement under this section shall submit an 
application to the Attorney General at such time, in such 
manner, and containing such information as the Attorney 
General may reasonably require, including— 
(1) a description of the objectives of the pro-
gram and activities to be funded by the grant or co-
operative agreement and how the grant or agree-
VerDate Sep 11 2014 
21:17 Oct 19, 2018
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7079.IH
H7079
pamtmann on DSKBFK8HB2PROD with BILLS
ment will be used to achieve these objectives, includ-
ing specific activities and services to be conducted; 
(2) a plan for measuring progress in achieving 
the objectives described in paragraph (1), including 
a strategy to collect data that can be used to meas-
ure such progress; 
(3) assurance that the prison or jail at which 
the program will be operated has, or has access to, 
a sufficient number of clinicians licensed to admin-
ister medication-assisted treatment to program par-
ticipants, which may include clinicians who are avail-
able using telemedicine; 
(4) a plan for ensuring secure storage of medi-
cations and protocols for diversion prevention; 
(5) a description of the program’s outreach and 
education component, in order to encourage max-
imum participation in the program; 
(6) assurance that the program will provide 
psychosocial counseling services to compliment medi-
cation-assisted treatment; and 
(7) a plan for ensuring that program partici-
pants have continuity of care, both with respect to 
medication-assisted 
treatment 
and 
psychosocial 
counseling services, through community service pro-
viders after release from incarceration, including 
VerDate Sep 11 2014 
21:17 Oct 19, 2018
Jkt 089200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7079.IH
H7079
pamtmann on DSKBFK8HB2PROD with BILLS
providing assistance to eligible participants in reg-
istering for Medicaid. 
(e) DURATION.—A grant awarded or cooperative 
agreement entered into under this section shall be for a 
period not to exceed 4 years, except that the Attorney 
General may extend the term of such a grant or agreement 
based on outcome data or extenuating circumstances. 
(f) COLLABORATION WITH CORRECTIONS ORGANIZA-
TION.—The Attorney General shall establish a working re-
lationship with a knowledgeable corrections organization 
with expertise in security, medical health, mental health, 
and addiction care, to oversee and support implementation 
of the program under this section, including the use of 
evidence-based clinical practices. 
(g) REPORT.— 
(1) IN GENERAL.—A jurisdiction that receives a 
grant or enters into a cooperative agreement under 
this section shall submit an annual report to the At-
torney General which includes information about the 
program funded by the grant or cooperative agree-
ment, including goals, interventions, outcomes (in-
cluding recidivism rates), and expenditures. 
(2) PUBLICATION.— 
(A) BY
RECIPIENT.—A jurisdiction that 
submits a report under paragraph (1) shall 
VerDate Sep 11 2014 
21:17 Oct 19, 2018
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H7079.IH
H7079
pamtmann on DSKBFK8HB2PROD with BILLS